The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for February 9, 2024
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA


Brakke Consulting News
Industry Overview at WVC
Pet Medications Home Delivery Study – now available
Complimentary WVC Seminars: Recruiting and Expanding into the Japanese Market

Earnings News
Central Garden & Pet
Hester Biosciences

Other News
BluePearl Pet Hospital
Bond Pet Foods
Camp Bow Wow
Central Life Sciences
Dagsmark Petfood
DaySmart Software
GNT Pharma
Lambarin Investimentos
Merck (Elanco aqua)
Merck (Innovax)
Merck (Allflex CleanVax)
Propelled Brands
Sumitomo Corporation
Time To Pet
VAFO Group

Brakke Consulting
2024 Industry Overview
Presented at WVC: Monday, February 19th, 2-4 pm, Four Seasons Hotel

How did the top animal health companies perform in 2023?  And what critical issues will impact industry performance in 2024?  Answers to these questions and more will be covered at Brakke Consulting’s annual Industry Overview at the 2024 WVC conference.  Key topics and presenters include:

  • Industry and top global company performance, presented by Bob Jones
  • What 2023 looked like in vet practices and with pets, presented by John Volk
  • An overview of the post-COVID home delivery channel for pet medications including results from the new Pet Medicines Home Delivery Study, presented by Rich Hayworth
  • With recent advancements in technology-related products in livestock production and pet care, where is the value and what are the risks? presented by Lourens Havenga

Also, you will be able to hear directly from a panel of top leaders in the animal health industry.  Moderated by Paul Casady, the topic for the panel will be “Opportunities and Challenges in 2024.” The panel for WVC will be:

  • Dr. Dan Markwalder, Chief Veterinary Officer, Mission Veterinary Partners.
  • Christine Royal, Vice President, US Companion Animal and Equine Business, Merck Animal Health.

This information-packed 2-hour session will be especially valuable for executive leadership, sales and marketing, strategy, and finance managers and for decision makers in the animal health industry.

Click here to register for WVC

You can also email Amanda McDavid or call at 336-396-3916. Registration cost is $399; there are discounts for multiple attendees from the same company.  We look forward to seeing you there!


  • IDEXX Laboratories announced results for the full year 2023. Revenue was $3,661 million, a year-over-year increase of 9% (+9% organic growth). Net income was $845 million compared to income of $679 million in 2022. Companion Animal Group revenue was $3,352 million, an increase of 10%. (company press release)
  • Phibro Animal Health Corporation announced financial results for its second quarter ended December 31, 2023. Company net sales were $205 million, an increase of 2%. Animal Health net sales were $173 million, an increase of 6%. (company press release)
  • Central Garden & Pet Company announced financial results for its fiscal 2024 first quarter ended December 30, 2023. Net sales for the Pet segment were $409 million, a decrease of 2%; organic net sales decreased 5% excluding the impact of the recent acquisition of TDBBS. Pet segment operating income was $43 million compared to $40 million a year ago, an increase of 10%. (company press release)
  • Hester Biosciences Ltd reported results for the third quarter of fiscal year 2024 ended December 2023. Revenue was Rs 66.98 crore ($8.0 million), a year-over-year decline of 11%. (

Brakke Consulting
Pet Medications Home Delivery Study – now available
Optimizing Pet Medicine Services: Key Insights into Home Delivery Channel

Discover critical insights for pet medicine businesses and veterinarians. Based on surveys of veterinarians and pet owners, as well as other primary research, the new Brakke Pet Medications Home Delivery Study will unveil current pet owner behaviors, emerging veterinary business trends, and the impact of online retailers on pet medication home delivery.

Leverage this knowledge to refine services, enhance customer experiences, and manage competitive challenges effectively. The proprietary research in this groundbreaking study will allow businesses to stay at the forefront of the evolving pet healthcare industry with current industry-backed data. Your success is our priority.

The report, priced at $14,500, is now available. For more information, contact Richard Hayworth at or 214.422.2025.


  • Merck Animal Health announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile. (company press release)
  • Merck Animal Health announced that INNOVAX-ILT-IBD vaccine is now commercially available as part of its poultry product portfolio. INNOVAX-ILT-IBD provides combined protection and immunization against Marek’s disease (MD), infectious laryngotracheitis (ILT) and infectious bursal disease (IBD) in a single injection. (company press release)
  • Merck Animal Health announced new Allflex CleanVax nozzles and shields for clean, fast and convenient administration of intranasal vaccines to cattle. (com)
  • Nextmune announced its acquisition of VetBiotek, underscoring Nextmune’s commitment to advancing dermatological care for pets. Financial terms were not disclosed. (com)
  • Hill’s Pet Nutrition and Bond Pet Foods announced a new joint development agreement to create an additional animal protein for potential use in Hill’s products. Bond is developing animal protein created through precision fermentation. (businesswire)
  • Neogen introduced the Provecta PRO Flea & Tick Collar for Dogs. The Provecta PRO collar contains deltamethrin (S)-methoprene and provides 6 months of protection. (company announcement)
  • Cargill announced it has partnered with Central Life Sciences to develop a feed-through fly control bolus for cattle containing Altosid IGR. Altosid IGR XRB releases the active ingredient, (S)-methoprene, consistently for up to 195 days. (com)
  • Propelled Brands with the support of private equity owners, LightBay Capital and Freeman Spogli, announced its acquisition of Camp Bow Wow. Camp Bow Wow has over 200 locations in 40 states and Canada. Financial terms were not disclosed. (Pet Business)
  • Wag! announced the successful completion of its acquisition of WoofWoofTV, which has a combined social media following of over 18 million pet lovers. Financial terms were not disclosed. (Pet Business)
  • DaySmart Software announced the acquisition of Time To Pet, a provider of pet care software. The acquisition brings pet sitting and dog walking capabilities to existing DaySmart Pet customers. Financial terms were not disclosed. (Pet Business)
  • Summit announced the launch of LIFT joint supplement for dogs and cats, containing medical grade chondroitin 4 sulfate with advanced patented technology that ensures the supplement can pass through the pet’s digestive system unharmed by stomach acid. (com)
  • BluePearl Pet Hospital announced the launch of its public charity, BluePearl Cares, a nonprofit organization created to make emergency and specialty veterinary care accessible for all. (DVM360)
  • BRAZIL Sumitomo Corporation and Lambarin Investimentos announced a joint investment in the seed funding round of Cyns, a biotechnology company that specializes in sustainable, insect-based animal nutrition. Cyns has developed a unique, cost competitive horizontal Black Soldier Fly rearing system that offers high bioconversion rates with minimum HVAC requirements. (Petfood Processing)
  • FINLAND VAFO Group announced it has acquired Dagsmark Petfood, a Finnish pet food producer, to expand its Nordic footprint.  Financial terms were not disclosed. (Globalpets)
  • DENMARK ATLINE ApS, a manufacturer of robotics for the pet food and animal feed industries, has been acquired by Indutrade. ATLINE’s annual sales are about DKK 40 million ($5.76 million). Financial terms were not disclosed. (Petfood Processing)
  • KOREA GNT Pharma announced an agreement with Pfizer’s contract manufacturing arm for overseas production of the company’s veterinary medication GedaCure, a chewable tablet of crisdesalazine used to treat dogs with cognitive dysfunction syndrome (CDS).  (com)

Brakke Consulting
Complimentary 1-hour seminars
Monday, February 19, 2024 at WVC
Four Seasons Hotel, Acacia Room

Stepping into the Japanese Animal Health Market
9:30 – 10:30 am
Would you like to grow your companion animal business outside the US but are not sure where and now?  How about in one of the most valuable markets in the world, Japan?  Brakke Consulting can help.

For the first time, Brakke Consulting will be presenting a seminar on taking the first step in Japan at the Western Veterinary Conference on Monday, February 19th from 9:30-10:30 am in the Acacia 1 room at the Four Seasons Hotel.  This seminar will be presented by Yuki Ujimasa, DVM, MS, a Brakke senior consultant based in Tokyo, who has broad experience in the Japanese market.  Yuki will focus on the steps needed to get your product approved by the regulatory authorities in Japan.  This will be a great seminar for companies looking to expand their global business but need some help to get started. There is no cost, but please RSVP here to secure your seat.

Recruiting Seminar

11:00 – 12:00 Noon
Hiring managers and talent professionals, join us for an informative and practical seminar at VMX hosted by Executive Recruiter Jeff Santosuosso. We’ll review and discuss the latest ways of breaking through the clutter to attract and hire top talent in today’s increasingly challenging global marketplace. Specific topics will include: attracting Millennials and Gen Z, using video, how to avoid pitfalls in recruiting, and more. If you’re in the market for talent, we know you’ll leave our seminar better equipped and more confident about hiring those stars for your team.  There is no cost, but please RSVP here to secure your seat.



  • US – PET REGULATION A bipartisan bill — dubbed the Petfax Act — has been introduced in the US House of Representatives, with the purpose of increasing transparency in the pet adoption process. If passed into law, the bill would require that a “Petfax” report detailing conditions in which the animal was bred and raised be provided to individuals who are purchasing pets. The Petfax Act would also establish stricter criteria for obtaining and maintaining licenses to sell pets. (DVM360)


February is National Pet Dental Month. Many of you have heard about this. Many actively promote it! The AVMA’s focus includes an instructional video, a photo contest, a veterinary tool kit, and more. There’s also a section designed for pet owners, describing various oral maladies and how veterinarians can help. Likewise, more suppliers are promoting the event, from food manufacturers to those marketing treats, rinses, gels, and other treatment forms.

We’re reminded that poor pet oral hygiene can lead to severe bacterial infections, resulting in diabetes, kidney disease, and heart disease (according to the American Veterinary Dental College). Increases in pet owner and veterinary awareness, plus advances in oral radiography and other technologies provide great promise, more precise diagnosis, and better prognosis.

Though this initiative is not new, one wonders how effective it is – and how effectively we’re managing it at a staff and client/patient level. What happens at the clinical level? In particular, to what degree are we leveraging staff? How confident are we that our technicians are prepared to manage screening of these cases we solicit? Can we optimize work flow for best patient and client outcomes, case management, and human resources?

Jeff Santosuosso


Last week’s question related to our “adoption curve” for long-acting parasiticides. Always a conservative bunch, our most popular response (41%) was about waiting for long-term adverse effects before adopting the technology. 24% would jump all over the idea, another 21% don’t need long-duration products or prefer a different form, while 14% would do so if their veterinarian recommended it.

This week
When you take your pet to the veterinarian, how involved have the veterinary technicians been in discussing dental care?














en_USEnglish (United States)